Peel Hunt reissued their buy rating on shares of UDG Healthcare (LON:UDG) in a research note issued to investors on Tuesday.
Several other research firms have also recently commented on UDG. Numis Securities reissued a reduce rating and set a GBX 765 ($10.26) target price on shares of UDG Healthcare in a research note on Tuesday, January 30th. Libertas Partners raised shares of UDG Healthcare to a buy rating and set a GBX 884 ($11.86) target price on the stock in a research note on Wednesday, February 7th. Liberum Capital reissued a buy rating on shares of UDG Healthcare in a research note on Tuesday. N+1 Singer reissued a hold rating and set a GBX 813 ($10.91) target price on shares of UDG Healthcare in a research note on Wednesday, February 7th. Finally, Barclays assumed coverage on shares of UDG Healthcare in a research note on Thursday, May 17th. They set an equal weight rating and a GBX 875 ($11.74) target price on the stock. One research analyst has rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the stock. UDG Healthcare currently has an average rating of Hold and a consensus price target of GBX 837.33 ($11.23).
UDG Healthcare stock opened at GBX 880.50 ($11.81) on Tuesday. UDG Healthcare has a 52 week low of GBX 690 ($9.26) and a 52 week high of GBX 963 ($12.92).
In other news, insider Chris Corbin sold 730,000 shares of UDG Healthcare stock in a transaction that occurred on Tuesday, March 13th. The shares were sold at an average price of GBX 870 ($11.67), for a total value of £6,351,000 ($8,521,400.78).
UDG Healthcare Company Profile
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services to the healthcare industry in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates through three segments: Ashfield, Sharp, and Aquilant.
Receive News & Ratings for UDG Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.